Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma : final analysis of PLEIADES and EQUULEUS - Moreau, Philippe (Hematology. University Hospital Hôtel-Dieu, France) ; Chari, Ajai (Icahn School of Medicine at Mount Sinai, New York, USA) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Martínez-López, Joaquín (Hospital Universitario 12 de Octubre (Madrid)) ; Haenel, M. (Klinikum Chemnitz, Germany) ; Touzeau, Cyrille (University Hospital Hôtel-Dieu, France) ; Ailawadhi, Sikander (Mayo Clinic Florida, USA) ; Besemer, Britta (Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Germany) ; de la Rubia Comos, Javier (Catholic University of Valencia) ; Encinas, Cristina (Hospital General Universitario Gregorio Marañón) ; Mateos, M. V (Hospital Universitario de Salamanca) ; Salwender, Hans (AK Altona and AK St. Georg, Hamburg, Germany) ; Rodriguez-Otero, Paula (Clínica Universidad de Navarra) ; Hulin, Cyrille (Hôpital Haut Lévêque. University Hospital, Pessac, France) ; Karlin, Lionel (Centre Hospitalier Lyon Sud. Hospices Civils de Lyon, France) ; Sureda Balari, Anna (Institut d'Investigació Biomèdica de Bellvitge) ; Bargay, Joan (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Benboubker, Lotfi (Centre Hospitalier Régional Universitaire (CHRU), France) ; Rosiñol, Laura (Hospital Clínic i Provincial de Barcelona) ; Tarantolo, Stefano (Nebraska Cancer Specialists, Omaha, USA) ; Terebelo, Howard (Providence Cancer Center, Southfield, USA) ; Yang, Shiyi (Janssen Research & Development. LLC, USA) ; Wang, Jianping (Janssen Research & Development. LLC, USA) ; Nnane, Ivo (Janssen Research & Development. LLC, USA) ; Qi, Ming (Janssen Research & Development. LLC, USA) ; Kosh, Michele (Janssen Research & Development. LLC, USA) ; Delioukina, Maria (Janssen Research & Development. LLC, USA) ; Goldschmidt, Hartmut (GMMG-Study Group at University Hospital Heidelberg, Germany)